Literature DB >> 35963916

Divergent synthesis of biologically active L-threo-β-hydroxyaspartates from common trans-oxazolidine dicarboxylate.

Yoonjae Lee1, Youngran Seo1, Boram Lee1, Hyuenyoung Kwon1, Kyungsu Chung1, Young Gyu Kim2.   

Abstract

A divergent synthetic strategy starting from a common trans-oxazolidine dicarboxylate intermediate has been successful to produce several non-proteinogenic L-threo-β-hydroxyaspartate derivatives efficiently with high stereoselectivity. Three bioactive α-amino-β-hydroxy acids, L-threo-β-hydroxyaspartic acid, L-threo-β-hydroxyasparagine, and L-threo-β-benzyloxyaspartic acid, were synthesized in good yields (58-83%) from the common chiral intermediate, and the chemoselective peptide bond formation at the α-amino group, β-hydroxy group, or α-carboxylic acid of the common intermediate was possible to afford the corresponding dipeptide, tripeptide, or didepsipeptide intermediate in 46~77% yields (in three-to-four steps) due to the orthogonal protective groups on the chiral intermediate.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Building block; Depsipeptide; L-threo-β-hydroxyaspartate; L-α-Amino-β-hydroxy acids; Trans-oxazolidine dicarboxylate

Year:  2022        PMID: 35963916     DOI: 10.1007/s00726-022-03196-8

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.789


  27 in total

1.  Asymmetric synthesis of orthogonally protected L-threo-beta-hydroxyasparagine.

Authors:  D L Boger; R J Lee; P Y Bounaud; P Meier
Journal:  J Org Chem       Date:  2000-10-06       Impact factor: 4.354

Review 2.  Recent developments in depsipeptide research.

Authors:  C E Ballard; H Yu; B Wang
Journal:  Curr Med Chem       Date:  2002-02       Impact factor: 4.530

Review 3.  Recent progress of the synthetic studies of biologically active marine cyclic peptides and depsipeptides.

Authors:  Yasumasa Hamada; Takayuki Shioiri
Journal:  Chem Rev       Date:  2005-12       Impact factor: 60.622

4.  Total synthesis of the ramoplanin A2 and ramoplanose aglycon.

Authors:  Wanlong Jiang; Jutta Wanner; Richard J Lee; Pierre-Yves Bounaud; Dale L Boger
Journal:  J Am Chem Soc       Date:  2003-02-19       Impact factor: 15.419

5.  One-Pot Production of L-threo-3-Hydroxyaspartic Acid Using Asparaginase-Deficient Escherichia coli Expressing Asparagine Hydroxylase of Streptomyces coelicolor A3(2).

Authors:  Ryotaro Hara; Masashi Nakano; Kuniki Kino
Journal:  Appl Environ Microbiol       Date:  2015-03-20       Impact factor: 4.792

6.  Ambiguity of NRPS Structure Predictions: Four Bidentate Chelating Groups in the Siderophore Pacifibactin.

Authors:  Clifford D Hardy; Alison Butler
Journal:  J Nat Prod       Date:  2019-03-14       Impact factor: 4.050

7.  An Operationally Simple and Efficient Synthesis of Orthogonally Protected L-threo-beta-Hydroxyasparagine.

Authors:  Aikomari Guzmán-Martinez; Michael S Vannieuwenhze
Journal:  Synlett       Date:  2007-06-01       Impact factor: 2.454

8.  A multistage, one-pot procedure mediated by a single catalyst: a new approach to the catalytic asymmetric synthesis of beta-amino acids.

Authors:  Ahmed M Hafez; Travis Dudding; Ty R Wagerle; Meha H Shah; Andrew E Taggi; Thomas Lectka
Journal:  J Org Chem       Date:  2003-07-25       Impact factor: 4.354

9.  Chemoenzymatic Synthesis of ortho-, meta-, and para-Substituted Derivatives of l-threo-3-Benzyloxyaspartate, An Important Glutamate Transporter Blocker.

Authors:  Jandré de Villiers; Marianne de Villiers; Edzard M Geertsema; Hans Raj; Gerrit J Poelarends
Journal:  ChemCatChem       Date:  2015-06-16       Impact factor: 5.686

10.  Chemoenzymatic Synthesis and Pharmacological Characterization of Functionalized Aspartate Analogues As Novel Excitatory Amino Acid Transporter Inhibitors.

Authors:  Haigen Fu; Jielin Zhang; Pieter G Tepper; Lennart Bunch; Anders A Jensen; Gerrit J Poelarends
Journal:  J Med Chem       Date:  2018-08-15       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.